Rothschild Investment Corp IL Cuts Stake in Metlife Inc (NYSE:MET)

Share on StockTwits

Rothschild Investment Corp IL reduced its holdings in shares of Metlife Inc (NYSE:MET) by 0.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 76,538 shares of the financial services provider’s stock after selling 473 shares during the period. Rothschild Investment Corp IL’s holdings in Metlife were worth $3,610,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. First Trust Advisors LP raised its position in shares of Metlife by 22.2% in the first quarter. First Trust Advisors LP now owns 1,073,448 shares of the financial services provider’s stock worth $45,697,000 after buying an additional 194,854 shares in the last quarter. Private Advisor Group LLC raised its position in Metlife by 32.7% during the first quarter. Private Advisor Group LLC now owns 35,750 shares of the financial services provider’s stock valued at $1,522,000 after purchasing an additional 8,801 shares in the last quarter. Lazard Asset Management LLC raised its position in Metlife by 2.4% during the first quarter. Lazard Asset Management LLC now owns 586,769 shares of the financial services provider’s stock valued at $24,978,000 after purchasing an additional 13,567 shares in the last quarter. Advisory Alpha LLC purchased a new stake in Metlife during the first quarter valued at about $27,000. Finally, Meiji Yasuda Asset Management Co Ltd. raised its position in Metlife by 10.1% during the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 27,833 shares of the financial services provider’s stock valued at $1,185,000 after purchasing an additional 2,555 shares in the last quarter. 75.55% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have weighed in on the company. Wells Fargo & Co raised their price target on Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, July 11th. Morgan Stanley lowered their price target on Metlife from $54.00 to $53.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 20th. ValuEngine downgraded Metlife from a “hold” rating to a “sell” rating in a research report on Thursday, August 1st. Citigroup decreased their price objective on Metlife from $42.00 to $41.00 and set a “sell” rating on the stock in a report on Friday, September 13th. Finally, Zacks Investment Research upgraded Metlife from a “sell” rating to a “hold” rating and set a $51.00 price objective on the stock in a report on Friday, August 2nd. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $49.51.

Shares of MET traded up $0.88 during trading hours on Friday, hitting $45.84. The company had a trading volume of 340,651 shares, compared to its average volume of 7,187,215. The firm has a market cap of $41.04 billion, a P/E ratio of 8.50, a P/E/G ratio of 0.92 and a beta of 1.12. The stock’s 50 day moving average price is $46.01 and its 200 day moving average price is $47.03. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 0.22. Metlife Inc has a 52-week low of $37.76 and a 52-week high of $51.16.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.38 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.07. The firm had revenue of $16.45 billion for the quarter, compared to the consensus estimate of $16.43 billion. Metlife had a return on equity of 9.75% and a net margin of 9.28%. The company’s quarterly revenue was down 22.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.30 earnings per share. On average, research analysts expect that Metlife Inc will post 5.68 EPS for the current fiscal year.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: What is the significance of a dead cat bounce?

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Royal Dutch Shell  Price Target Cut to GBX 2,780 by Analysts at Jefferies Financial Group
Royal Dutch Shell Price Target Cut to GBX 2,780 by Analysts at Jefferies Financial Group
Domino’s Pizza Group  Rating Reiterated by Canaccord Genuity
Domino’s Pizza Group Rating Reiterated by Canaccord Genuity
Deutsche Telekom  Given a €17.00 Price Target at Credit Suisse Group
Deutsche Telekom Given a €17.00 Price Target at Credit Suisse Group
MediBloc [QRC20]  Price Hits $0.0041
MediBloc [QRC20] Price Hits $0.0041
Dropil Market Capitalization Tops $4.12 Million
Dropil Market Capitalization Tops $4.12 Million
Molecular Future  Tops 24 Hour Trading Volume of $20.18 Million
Molecular Future Tops 24 Hour Trading Volume of $20.18 Million


 
© 2006-2019 Zolmax.